Science

  • Bio
    Women’s health startup Celmatix now offers genetic testing for fertility issues

    Women’s health startup Celmatix now offers genetic testing for fertility issues

    Celmatix, a startup with a focus on personalized medicine for women, wants to take some of the mystery out of the science of baby-making with a new type of DNA-based fertility test called Fertilome. Fertilome looks at 49 variants in 32 genes that give you a likelihood or not for inherited disorders such as endometriosis or PCOS to help women determine the best course of action to take based… Read More

  • This 20-cent whirligig toy can replace a $1,000 medical centrifuge

    This 20-cent whirligig toy can replace a $1,000 medical centrifuge

    Centrifuges are found in medical labs worldwide. But a good one could run you a couple grand and, of course, requires electricity — neither of which are things you’re likely to find in a rural clinic in an impoverished country. Stanford researchers have created an alternative that costs just a few cents and runs without a charge, based on a children’s toy with surprising… Read More

  • Bio
    Illumina wants to sequence your whole genome for $100

    Illumina wants to sequence your whole genome for $100

    The first sequencing of the whole human genome in 2003 cost roughly $2.7 billion, but DNA sequencing giant Illumina has now unveiled a new machine that the company says is “expected one day” to order up your whole genome for less than $100. Illumina’s CEO Francis deSouza showed off the machine, called the NovaSeq, onstage at the JP Morgan Healthcare Conference in downtown… Read More

  • Uber’s David Plouffe will run politics for the Chan Zuckerberg Initiative

    Uber’s David Plouffe will run politics for the Chan Zuckerberg Initiative

    If you want to cure all disease and educate everyone, you’re going to need the government’s help, even if you’re as rich as Mark Zuckerberg. Today, he and his wife Priscilla’s philanthropic vehicle the Chan Zuckerberg Initiative announced it’s hired away Uber’s chief advisor and former Obama campaign manager David Plouffe to lead its policy and advocacy team. Read More

  • Bio
    Grail is raising at least $1 billion to fund its early cancer screening test

    Grail is raising at least $1 billion to fund its early cancer screening test

    The early cancer screening startup Grail plans to raise more than $1 billion in Series B financing, possibly up to $1.8 billion. While the company doesn’t want to name investor names, only mentioning in a release the funding will come “primarily from undisclosed private and strategic investors,” Microsoft co-founder Bill Gates, Amazon founder Jeff Bezos, Google Ventures… Read More

  • Venneos launches a device for faster, better imaging of individual cells in biotech

    Venneos launches a device for faster, better imaging of individual cells in biotech

    The imaging technologies used in the medical and biotech fields may be powerful and indispensable for research and diagnosis, but they also can be slow and clumsy — relics of techniques that go back decades. Venneos wants to change that with its new device, which allows easy and continuous monitoring of a handful of individual cells without any of the fuss or mystery of existing solutions. Read More

  • SOSV, “the accelerator VC,” closes third fund at $150 million

    SOSV, “the accelerator VC,” closes third fund at $150 million

    Since the advent of accelerators, venture capitalists have competed to lock in deals with the best startups in a given batch. Entrepreneur turned investor Sean O’ Sullivan thought it would be better to develop a venture firm that owned and ran its own accelerators. Today that firm, SOSV, has closed its third fund at $150 million to back startups that are admitted to and have graduated… Read More

  • How technology is merging with the human body Crunch Network

    How technology is merging with the human body

    The gulf between “human” and “machine” is closing. Machine learning has enabled virtual reality to feel more “real” than ever before, and AI’s replication of processes that were once confined to the human brain is ever-improving. Both are bringing technology into ever-closer proximity with the human body. Things are getting weird. And they are going to… Read More

  • Neurable nets $2 million to build brain-controlled software for AR and VR

    Neurable nets $2 million to build brain-controlled software for AR and VR

    As consumers get their first taste of voice-controlled home robots and motion-based virtual realities, a quiet swath of technologists are thinking big picture about what comes after that. The answer has major implications for the way we’ll interact with our devices in the near future. Spoiler alert: We won’t be yelling or waving at them; we’ll be thinking at them. That answer… Read More

  • Bio
    Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis

    Move over Cas9, CRISPR-Cas3 might hold the key to solving the antibiotics crisis

    Researchers at North Carolina-based Locus Biosciences think they have a potential cure for antibiotic resistance using CRISPR’s lesser-known Cas3 enzyme. Most of the interest in CRISPR technology centers around the enzyme Cas9, which acts as a type of genetic scissors, allowing scientists to snip out, edit and replace DNA at certain intervals along the genome. However, Cas3 goes beyond… Read More

  • Artificial leaf captures light to power drug production

    Artificial leaf captures light to power drug production

    Drug production is generally a matter of big factories churning out millions of aspirin or ibuprofen tablets a day, but there’s a lot to be said for manufacturing common drugs on a small scale, close to where they’re used. Researchers from the Netherlands have created an efficient and simple method for doing so that uses a method much like plants have for making their own resources. Read More

  1. 1
  2. 2
  3. ...